InvestorsHub Logo
Followers 31
Posts 3487
Boards Moderated 0
Alias Born 07/02/2004

Re: None

Tuesday, 10/28/2014 8:51:52 PM

Tuesday, October 28, 2014 8:51:52 PM

Post# of 97237
CANF

Bought shares of canfite today at $2.85. This is a
low float bio with phase 2/3 topline psoriasis results expected in Q1 2015.

Company has orphan designation for cf102 liver drug, which has been approved for compassionate use in Israel.

March 2014 $5 million raise was done at $5.15 a share.

With the IBB setting new highs, CANF has been making new lows.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.